CL
PGNX

CSS LLC’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

CSS LLC’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-350,672
Closed -$1.33M – 803
2020
Q1 		$1.33M Buy
+350,672
New +$1.51M 0.11% 176

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

CSS LLC's PGNX Position: Q2 2020 in Review

CSS LLC sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 350,672 shares — an estimated $1.33M sold.

CSS LLC first reported a position in PGNX in Q1 2020 and held it in 1 quarter. The position peaked at $1.33M in Q1 2020. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • CSS LLC reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • CSS LLC sold 350,672 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $1.33M.
  • CSS LLC first reported a position in Progenics Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
  • CSS LLC's Progenics Pharmaceuticals Inc position peaked at $1.33M in Q1 2020.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on CSS LLC's 13F filing for Q2 2020, filed 14 Aug 2020.